Search research articles
Contact Us
Filters
Showing results (21-30 of 188) with videos related to
Page
of 19
Sort By:
Current Oncology Reports
|
June 5, 2002
Chemoprevention of lung cancer
Edward S Kim, Fadlo R Khuri
JAMA Oncology
|
September 2, 2016
Mutational Markers and Risk Stratification in Thyroid Cancer-The Art of War Refined
E Shannon Story, Edward S Kim
Current Oncology Reports
|
June 5, 2002
Angiogenesis inhibitors in lung cancer
Edward S Kim, Roy S Herbst
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2016
Who's Eligible Anyway? Risk Modeling for Clinical Trial Accrual
Kathryn F Mileham, Edward S Kim
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 16, 2020
Response to Letter to the Editor
James R Jett, Edward S Kim
Journal of Global Oncology
|
February 28, 2019
Clinical Use of Epidermal Growth Factor Receptor Testing in Patients With Advanced Lung Cancer by Physicians: Survey of US and International Patterns
Matthew Peters, Edward S Kim, Vera Hirsch
Current Opinion in Oncology
|
September 3, 2010
Bevacizumab: current updates in treatment
Margaret Em Van Meter, Edward S Kim
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 26, 2023
Response to: Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population?
Sai-Hong Ignatius Ou, Edward S Kim
Seminars in Respiratory and Critical Care Medicine
|
July 30, 2005
New biological agents in the treatment of advanced non-small cell lung cancer
Phuong Khanh H Morrow, Edward S Kim
Current Opinion in Oncology
|
May 1, 2002
Novel therapeutics for head and neck cancer
Edward S Kim, Merrill Kies, Roy S Herbst
Page
of 19
Search research articles
Search
Showing results (21-30 of 188) with videos related to
Sort By:
Page
of 19
Current Oncology Reports
|
June 5, 2002
Chemoprevention of lung cancer
Edward S Kim, Fadlo R Khuri
JAMA Oncology
|
September 2, 2016
Mutational Markers and Risk Stratification in Thyroid Cancer-The Art of War Refined
E Shannon Story, Edward S Kim
Current Oncology Reports
|
June 5, 2002
Angiogenesis inhibitors in lung cancer
Edward S Kim, Roy S Herbst
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 8, 2016
Who's Eligible Anyway? Risk Modeling for Clinical Trial Accrual
Kathryn F Mileham, Edward S Kim
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 16, 2020
Response to Letter to the Editor
James R Jett, Edward S Kim
Journal of Global Oncology
|
February 28, 2019
Clinical Use of Epidermal Growth Factor Receptor Testing in Patients With Advanced Lung Cancer by Physicians: Survey of US and International Patterns
Matthew Peters, Edward S Kim, Vera Hirsch
Current Opinion in Oncology
|
September 3, 2010
Bevacizumab: current updates in treatment
Margaret Em Van Meter, Edward S Kim
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 26, 2023
Response to: Efficacy of Brigatinib After Progression on Alectinib or Ceritinib: Does One Drug Work in a Pretreated Heterogeneous ALK-Positive NSCLC Population?
Sai-Hong Ignatius Ou, Edward S Kim
Seminars in Respiratory and Critical Care Medicine
|
July 30, 2005
New biological agents in the treatment of advanced non-small cell lung cancer
Phuong Khanh H Morrow, Edward S Kim
Current Opinion in Oncology
|
May 1, 2002
Novel therapeutics for head and neck cancer
Edward S Kim, Merrill Kies, Roy S Herbst
Page
of 19